Molina Healthcare (MOH) – Analysts’ Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of Molina Healthcare (NYSE: MOH) recently:

• 6/8/2026 – Molina Healthcare was given a new $215.00 price target by Mizuho.
• 6/8/2026 – Molina Healthcare had its price target raised by JPMorgan Chase & Co. from $169.00 to $191.00. They now have a “neutral” rating on the stock.
• 6/4/2026 – Molina Healthcare had its price target raised by Morgan Stanley from $146.00 to $167.00. They now have an “equal weight” rating on the stock.
• 5/26/2026 – Molina Healthcare had its price target raised by Barclays PLC from $161.00 to $199.00. They now have an “underweight” rating on the stock.
• 5/22/2026 – Molina Healthcare had its price target raised by UBS Group AG from $180.00 to $202.00. They now have a “neutral” rating on the stock.
• 5/11/2026 – Molina Healthcare had its price target raised by Truist Financial Corporation from $180.00 to $205.00. They now have a “hold” rating on the stock.
• 5/11/2026 – Molina Healthcare had its price target raised by Cantor Fitzgerald from $144.00 to $209.00. They now have a “neutral” rating on the stock.
• 5/11/2026 – Molina Healthcare had its price target raised by Robert W. Baird from $124.00 to $163.00. They now have a “neutral” rating on the stock.
• 5/2/2026 – Molina Healthcare was upgraded by Wall Street Zen from “sell” to “hold”.
• 4/29/2026 – Molina Healthcare was upgraded by Bank of America Corporation from “underperform” to “buy”. They now have a $250.00 price target on the stock.
• 4/27/2026 – Molina Healthcare had its price target raised by Wells Fargo & Company from $141.00 to $159.00. They now have an “equal weight” rating on the stock.
• 4/27/2026 – Molina Healthcare had its price target raised by Truist Financial Corporation from $145.00 to $180.00. They now have a “hold” rating on the stock.
• 4/24/2026 – Molina Healthcare had its “hold” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a $129.00 price target on the stock.
• 4/24/2026 – Molina Healthcare had its price target raised by UBS Group AG from $151.00 to $180.00. They now have a “neutral” rating on the stock.
• 4/24/2026 – Molina Healthcare had its price target raised by Morgan Stanley from $128.00 to $146.00. They now have an “equal weight” rating on the stock.
• 4/24/2026 – Molina Healthcare had its price target raised by Barclays PLC from $133.00 to $161.00. They now have an “underweight” rating on the stock.
• 4/21/2026 – Molina Healthcare had its “sell (d+)” rating reaffirmed by Weiss Ratings.
• 4/20/2026 – Molina Healthcare was upgraded by Zacks Research from “strong sell” to “hold”.
• 4/19/2026 – Molina Healthcare was upgraded by Wall Street Zen from “strong sell” to “sell”.
• 4/11/2026 – Molina Healthcare was downgraded by Wall Street Zen from “sell” to “strong sell”.

Insider Buying and Selling

In other Molina Healthcare news, CAO Maurice Hebert sold 600 shares of the stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the sale, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the transaction, the insider owned 67,175 shares in the company, valued at $12,502,611. The trade was a 20.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.44% of the stock is currently owned by company insiders.

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.